| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |